Xu Cong Claire, EVP, CD, reported an open-market or private sale at NovaBridge Biosciences involving 3282.000000 shares for an estimated $2592.78. Reported holdings after the transaction were 304201.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.
Form 4 relationship flags and nearby filing context
EVP, Clinical Development
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
Reported securities are represented by 4,079 ADSs.
Each restricted stock unit ("RSU") represents a contingent right to receive one ADS.
Reported securities are represented by 133,688 ADSs.
Reported securities are represented by 1,427 ADSs.
Reported sales price represents the converted sales price of the ADSs of $1.8186.
Reported securities are represented by 132,261 ADSs.
Reported securities represent ADSs.
On May 30, 2024, the Reporting Person was granted 65,270 RSUs. The RSUs vested or shall vest over four years, with one-fourth vesting on the first anniversary of the grant date and the balance vesting…
0 other filings
0 recent txs